Treatments for MS include those that help reduce relapses in MS and relieve symptoms, as well as therapies that can improve a person’s ability to function and to take part in their day-to-day activities.

Disease-modifying treatments aim to prevent or reduce the number of MS relapses that occur and thereby reduce the accumulation of disability over the person’s lifetime.

When disease-modifying treatments do not work effectively, or a relapse occurs, there are other treatment options available.

We also outline some of the complementary or alternative therapies that people with MS may use alongside conventional treatments.

This information should not be relied on to suggest a course of treatment for a particular individual, and it should not be used in place of a visit, call, consultation or the advice or a physician or other qualified healthcare provider. You should contact or see your physician or other qualified healthcare provider promptly if you have any questions or before embarking on a new treatment, diet, or fitness programme.

A man injects his girlfriend with Interferon-b

Aversa, Italy, 03/2012. Like many people with MS, Stefania Salzillo finds it difficult to cope with the daily injections of Interferon-b. Her boyfriend, Ernesto Lodice, helps out providing both practical and emotional support. But access to medication was relatively quick: she received her first prescription within two months of being diagnosed. The cost of DMDs in Italy is 100% covered by the national health plan. Credit: Walter Astrada. Published on this website by kind permission of the European Multiple Sclerosis Platform.

A Greek woman with MS in a motorised scooter

Thessaloniki, Greece, 10/2011. Finding an effective MS therapy has been a particular challenge for Vasiliki Garopoulou; every medication she tried has caused intolerable side effects. On average, she has a relapse once per month, many of which land her in hospital for cortisone treatment. Credit: Maximiliano Braun. Published on this website by kind permission of the European Multiple Sclerosis Platform.